The race to develop a COVID-19 vaccine is gaining ground in many parts of the world. The government of India is in close coordination with leading Indian vaccine manufacturers at the forefront of the effort. Once an effective and safe vaccine is developed, India will have to ensure fair and equitable distribution among its large and diverse population.
This discussion will focus on how the Government of India is ensuring a supportive ecosystem accelerating vaccine candidate development, clinical trials, and manufacturing. How are efficacy and safety being ensured by companies in a situation of challenging timelines and heightened public scrutiny? How are companies negotiating uncertainties in terms of returns to investment and the need for equitable distribution?
SPEAKERS
Gagandeep Kang, Professor, Christian Medical College, VelloreK. Vijay Raghavan, Principal Scientific Advisor to the Government of India
Chair
Kanchan Gupta, Distinguished Fellow, ORF
#COVID19 #Coronavirus #COVIDVaccine
